CEA as a prognostic index in colorectal cancer
Frontiers | From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades
Adjuvant intra-arterial chemotherapy for patients with resected colorectal liver metastases: a systematic review and meta-analysis - HPB
Cancers | Free Full-Text | Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries | HTML
Download PDF | Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA | British Journal of Cancer
Cancers | Free Full-Text | Toll-Like Receptor-4 Antagonist Enhances the Repair of Ultraviolet Radiation-Induced DNA Damage and Augments Anti-Tumor Immune Responses in Mice | HTML
Tumor Marker Evolution: Comparison with Imaging for Assessment of Response to Chemotherapy in Patients with Colorectal Liver Metastases | SpringerLink
PDF) CA 242, a new tumour marker for pancreatic cancer: A comparison with CA 19-9, CA 50 and CEA
Sekbio CA 242 Tumor Marker, CA 242 Blood Test Manufacturer
CA 242 | RT Diagnostics
Inflammation and tumor progression: signaling pathways and targeted intervention | Signal Transduction and Targeted Therapy
Analize medicale - Markeri tumorali | Bioclinica
PDF) CA125 and CA242 markers' role in colorectal cancer diagnosis and management – a 30 year review
Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD+ and SIRT3 | Cell Death & Differentiation
CA 242 | RT Diagnostics
CA242 as a biomarker for pancreatic cancer and other diseases - ScienceDirect
Nanomedicines Targeting Glioma Stem Cells | ACS Applied Materials & Interfaces
Cancers | Free Full-Text | Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries | HTML
Cells | Free Full-Text | Autophagy Contributes to Metabolic Reprogramming and Therapeutic Resistance in Pancreatic Tumors | HTML
Biomedicines | Free Full-Text | Concerted Regulation of Glycosylation Factors Sustains Tissue Identity and Function | HTML
PDF) Collagenase-3 (MMP-13) Expression in Cutaneous Malignant Melanoma
Sekbio CA 242 Tumor Marker, CA 242 Blood Test Manufacturer
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA | British Journal of Cancer
Evaluation of PD-L1 and other immune markers in bladder urothelial carcinoma stratified by histologic variants and molecular subtypes | Scientific Reports
Serum concentrations of CA 242 in patients with various benign (0) and... | Download Scientific Diagram
